ChronoScale

Borrower

ChronoScale Holdings Corporation (borrower); Applied Digital Corporation, the former parent, as lender

Seniority

Unsecured

Maturity

Payable on demand — Applied Digital has agreed not to exercise its demand right before 2027-08-20.

Lenders

Applied Digital Corporation

Pricing

Short-term Applicable Federal Rate, compounded semi-annually. The AFR is the tax-minimum reference rate under IRC s.1274(d), so it is not a market spread and must not be read as one.

Terms

Aggregate principal available of up to $100.0M, reduced by the value of any ChronoScale liabilities the lender guarantees and by a reserve amount the lender determines, so the lender may reduce availability unilaterally. $7.0M drawn 2026-07-01. Parent-support financing for the carved-out GPU cloud rather than third-party credit.

Source: CHRN 10-K for the fiscal year ended 2026-05-31, Note 8 Debt, filed 2026-08-19, acc 0001628280-26-058018 · document

Borrower

ChronoScale Corporation (the GPU cloud; formerly Applied Digital Cloud Corporation)

Seniority

Finance lease

Maturity

2028 — Payments extended through fiscal year 2028 after two renegotiations.

Collateral

Leased GPU computing equipment

Lenders

Not named

Pricing

Implicit rate not disclosed in the 10-K.

Terms

$47.6M current plus $10.7M long-term at 2026-05-31, against $133.4M current a year earlier. Finances the deployed GPU fleet: 6,144 NVIDIA H100s across colocation sites in Colorado, Minnesota and Utah. The leases were renegotiated in FY2025 to extend amortisation to five years and again after FY2025 to extend payments through fiscal 2028. The cloud business was acquired by Ekso Bionics Holdings in the 2026-05-05 business combination and reorganised under a holding company on 2026-07-01.

Source: CHRN 10-K for the fiscal year ended 2026-05-31, Note 8 Debt, filed 2026-08-19, acc 0001628280-26-058018 · document

Borrower

Borrower: ChronoScale Intermediate, LLC (f/k/a Ekso Bionics Holdings, Inc. and ChronoScale Corporation), Nevada LLC; Guarantor: Ekso Bionics, Inc. (Delaware). Both wholly owned subsidiaries of ChronoScale Holdings Corporation.

Seniority

Senior secured; ranks ahead of the Parker Hannifin note

Maturity

2026-11-12 — The earlier of a Qualified Financing (receipt of $2.4M net proceeds from the sale of equity interests of the Borrower to new equity investors) and 2026-11-12. First Amendment effective 2026-09-12 "extends the Maturity Date described in clause (i) above to November 12, 2026"; the Proposed Financing under the 2026-04-23 Waiver "shall not constitute a Qualified Financing for purposes of accelerating the Maturity Date" but is one for the Section 10 conversion right.

Collateral

Security agreement over company and subsidiary assets; covenants limit debt, liens, asset disposals and restricted payments. First Amendment adds a Permitted Disposition: the sale of the Guarantor (Ekso Bionics, Inc.) by asset sale, stock sale, merger or otherwise; on consummation the Lender's liens on the Released Collateral are released "without any payment to the Lender as a condition thereto" (new §11(l)); carved out of the §6(a) disposition restriction and of Change of Control. All other Collateral continues to secure the Note.

Lenders

B. Riley Commercial Capital, LLC

Pricing

10% per annum, payable in full at maturity, plus an exit fee of 10% of the original principal ($0.2M) due at maturity. Prepayment requires payment of all interest that would have accrued through maturity plus the proportionate exit fee.

Terms

Secured term loan of up to $2.0M; $2.0M principal outstanding at the date of the 10-K. Recorded at an acquisition-date fair value of $2.239M under ASC 805. B. Riley may elect to convert principal, interest and the exit fee into equity in a qualified financing at the lead investor's price per share. Assumed in the 2026-05-05 business combination; originally entered by Legacy Ekso in September 2025. First Amendment §2(a) (2026-09-12): "the principal amount outstanding under the Note on the date hereof is $2,000,000.00".

Source: CHRN 8-K Item 1.01 (event 2026-09-12, filed 2026-09-16), acc 0001493152-26-042947, with EX-10.1 First Amendment to Secured Promissory Note and Security Agreement; 10-K FYE 2026-05-31 Note 8 for original terms · document

Borrower

ChronoScale Holdings Corporation (assumed from Ekso Bionics Holdings)

Seniority

Unsecured; subordinated to the B. Riley Secured Promissory Note

Maturity

2027-09-30 — Principal payable in equal instalments on the last day of each calendar quarter.

Lenders

Parker Hannifin Corporation

Pricing

Non-interest-bearing; the 22.7% effective rate for 2026-05-05 to 2026-05-31 is accretion of the acquisition-date debt discount, not a contractual coupon. On default, interest at the lesser of 5% per annum and the maximum permitted by law.

Terms

$1.875M principal outstanding at 2026-05-31 ($1.25M due in fiscal 2027, $0.625M in fiscal 2028); $1.574M net of a $0.301M debt discount. Recorded at an acquisition-date fair value of $1.571M under ASC 805. Assumed in the 2026-05-05 business combination; originally issued by Legacy Ekso.

Source: CHRN 10-K for the fiscal year ended 2026-05-31, Note 8 Debt, filed 2026-08-19, acc 0001628280-26-058018 · document